Titrate based on glucose level
This individualized care is why we strongly advise against unsupervised or compounded sources
We will continue to scrutinise the data to see whether abnormal blood test results such as having pre-diabetes might predict a better response to exenatide, and whether there were more of these people in the earlier, smaller trials in which we found positive overall effects. The trial was supported by the UCL Comprehensive Clinical Trials Unit (UCL CCTU), the National Institute for Health and Care Research (NIHR), UCLH Biomedical Research Centre and the NIHR UCLH Clinical Research Facility
For type 2 diabetes, these include semaglutide (Ozempic), dulaglutide (Trulicity), liraglutide (Victoza), and exenatide (Byetta, Bydureon)
By stimulating the GLP-1 receptor, Semaglutide slows digestion, reduces appetite, and can significantly lower blood sugar levels